• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall McFarland Standard

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall McFarland Standard see related information
Date Initiated by Firm September 22, 2008
Date Posted January 28, 2009
Recall Status1 Terminated 3 on July 06, 2010
Recall Number Z-0669-2009
Recall Event ID 50129
Product Classification in vitro diagnostic - Product Code JTZ
Product HARDY DIAGNOSTIC McFarland Standard 0.5; in vitro diagnostic, glass vial, one vial per box
Code Information Model Number: Hardy = MSO5; Lot number 08182; Expiration date: 10/28/08
Recalling Firm/
Manufacturer
Trek Diagnostic Systems
982 Keynote Cir Ste 6
Cleveland OH 44131-1873
For Additional Information Contact Teresa Anacker
608-837-3788 Ext. 224
Manufacturer Reason
for Recall
Incorrect result: The absorbance has changed as the standards have aged; the standards' turbidity has become denser. The recalled lot is now reading 0.15 ABS @ 625 nm. TREK'S internal specification and the manufacturer's (Hardy Diagnostics) specification is 0.08 - 0.10 ABS @625 nm. CLSI specifies 0.08 - 0.13 ABS @ 625 nm.
FDA Determined
Cause 2
Nonconforming Material/Component
Action On 9/22/2008 TREK Diagnostic sent a recall notification letter to their customers advising them of the problem with the product. They instructed their customers to inventory their stock for any remaining recall lot and immediately destroy.
Quantity in Commerce 4 vials
Distribution USA distribution in OH and IL.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-